- Home
- MCVT vs PHIO Comparison
MCVT vs PHIO Comparison
Compare MCVT & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- PHIO
- Stock Information
- Founded
- MCVT 2007
- PHIO 2011
- Country
- MCVT United States
- PHIO United States
- Employees
- MCVT N/A
- PHIO N/A
- Industry
- MCVT Finance Companies
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- MCVT Finance
- PHIO Health Care
- Exchange
- MCVT Nasdaq
- PHIO Nasdaq
- Market Cap
- MCVT 9.3M
- PHIO 8.6M
- IPO Year
- MCVT N/A
- PHIO N/A
- Fundamental
- Price
- MCVT $1.83
- PHIO $2.23
- Analyst Decision
- MCVT
- PHIO Strong Buy
- Analyst Count
- MCVT 0
- PHIO 2
- Target Price
- MCVT N/A
- PHIO $9.00
- AVG Volume (30 Days)
- MCVT 16.1K
- PHIO 702.3K
- Earning Date
- MCVT 08-13-2025
- PHIO 08-13-2025
- Dividend Yield
- MCVT N/A
- PHIO N/A
- EPS Growth
- MCVT N/A
- PHIO N/A
- EPS
- MCVT 0.19
- PHIO N/A
- Revenue
- MCVT $3,246,479.00
- PHIO N/A
- Revenue This Year
- MCVT N/A
- PHIO N/A
- Revenue Next Year
- MCVT N/A
- PHIO N/A
- P/E Ratio
- MCVT $9.65
- PHIO N/A
- Revenue Growth
- MCVT N/A
- PHIO N/A
- 52 Week Low
- MCVT $1.13
- PHIO $0.97
- 52 Week High
- MCVT $3.88
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- MCVT 50.24
- PHIO 50.19
- Support Level
- MCVT $1.77
- PHIO $2.11
- Resistance Level
- MCVT $1.91
- PHIO $2.30
- Average True Range (ATR)
- MCVT 0.08
- PHIO 0.21
- MACD
- MCVT -0.01
- PHIO -0.04
- Stochastic Oscillator
- MCVT 36.11
- PHIO 9.65
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.